According to Zhitong Finance App, Hengrui Pharmaceutical (01276.HK) issued an announcement. On August 19, 2026, the board of directors decided to recommend adopting the 2026 H share plan (2026 H share plan). The 2026 H share plan will take effect after approval at the upcoming 2026 First Extraordinary General Meeting of Shareholders (Shareholders Meeting) of the Company.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.